NCT00539578已完成2 期
A Double-Blind, Mulitcenter, Placebo-Controlled, Flexible-Dose Replicate Study of MK0777 Gel Extrusion Module (GEM) 3 mg B.I.D. to 8 mg B.I.D. in the Treatment of Outpatients With Generalized Anxiety Disorder
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 270
研究概览
简要总结
The purpose of the study is to examine the safety and efficacy of MK0777 during treatment for Generalized Anxiety Disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and Female patients ages 18 to 70
排除标准
- •Women who are breastfeeding or pregnant
- •Positive result at prestudy on urine drug screen for illicit drugs
- •History of alcohol or drug abuse
研究者
相似试验
已完成
1 期
Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)HealthyNCT01017458Merck Sharp & Dohme LLC68
已完成
2 期
A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary IncontinenceStress Urinary IncontinenceNCT05674045Changchun GeneScience Pharmaceutical Co., Ltd.51
已完成
2 期
Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.Primary Biliary CirrhosisNCT03226067Calliditas Therapeutics AB111
已完成
1 期
Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)Alzheimer's DiseaseNCT06285240Merck Sharp & Dohme LLC28
已完成
3 期
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)Rhinitis, Allergic, PerennialRhinitis, Allergic, NonseasonalNCT01700192ALK-Abelló A/S1,482